David Leslie Szekeres - Net Worth and Insider Trading
David Leslie Szekeres Net Worth
The estimated net worth of David Leslie Szekeres is at least $0 dollars as of 2024-09-20. David Leslie Szekeres is the EVP, COO of Heron Therapeutics Inc and owns about 0 shares of Heron Therapeutics Inc (HRTX) stock worth over $0. Details can be seen in David Leslie Szekeres's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Leslie Szekeres has not made any transactions after 2021-01-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Leslie Szekeres
David Leslie Szekeres Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Leslie Szekeres owns 3 companies in total, including Heron Therapeutics Inc (HRTX) , Regulus Therapeutics Inc (RGLS) , and GRI Bio Inc (GRI) .
Click here to see the complete history of David Leslie Szekeres’s form 4 insider trades.
Insider Ownership Summary of David Leslie Szekeres
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2021-01-14 | EVP & Chief Operating Officer |
| RGLS | Regulus Therapeutics Inc | 2014-03-10 | See Remarks |
| GRI | GRI Bio Inc | 2023-04-21 | director |
David Leslie Szekeres Latest Holdings Summary
David Leslie Szekeres currently owns a total of 1 stock. David Leslie Szekeres owns 0 shares of Heron Therapeutics Inc (HRTX) as of January 14, 2021, with a value of $0.
Latest Holdings of David Leslie Szekeres
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2021-01-14 | 0 | 2.01 | 0 |
Holding Weightings of David Leslie Szekeres
David Leslie Szekeres Form 4 Trading Tracker
According to the SEC Form 4 filings, David Leslie Szekeres has made a total of 2 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Heron Therapeutics Inc is the sale of 827 shares on January 14, 2021, which brought David Leslie Szekeres around $14,960.
Insider Trading History of David Leslie Szekeres
- 1
David Leslie Szekeres Trading Performance
David Leslie Szekeres Ownership Network
David Leslie Szekeres Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
David Leslie Szekeres is the EVP & Chief Operating Officer of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, David Leslie Szekeres made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
David Leslie Szekeres Mailing Address
Above is the net worth, insider trading, and ownership report for David Leslie Szekeres. You might contact David Leslie Szekeres via mailing address: C/o Regulus Therapeutics Inc., 3545 John Hopkins Court, Suite 210, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
